SCHEMBL16401243

SCHEMBL16401243

CC1(C)CCN(C(=O)O)C(=O)C1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 6/20 0.36
PKM P14618 1/20 0.30
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14157206 0.79 GRM5 (0.33) GRM5
SCHEMBL14157270 0.72 LMNA (0.32)
SCHEMBL1966889 0.72
SCHEMBL29860723 0.72 CYP11B1 (0.31)
SCHEMBL2120814 0.71 FFAR3 (0.32) FFAR3
SCHEMBL14959573 0.70 BRD4 (0.41) GRM5PKM
SCHEMBL23542652 0.68 PKM (0.36) GRM5PKM
SCHEMBL8007382 0.67 CHRM2 (0.36)
SCHEMBL25275893 0.67 ITGB3 (0.30)
SCHEMBL2225143 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105579444-B Piperidinylindole derivatives and their use as complement factor B inhibitors 诺华股份有限公司 2018-05-01 CN disclosed
EP-3022192-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS Novartis AG (CH) 2016-05-25 EP disclosed
WO-2015009616-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS NOVARTIS AG (CH) 2015-01-22 WO disclosed